Abstract
Introduction: Alirocumab is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9) that is administered by subcu......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
